MOESM1 of Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study
2020-01-08T04:57:01Z (GMT) by
Additional file 1: Table S1. ICD-9-CM code used for diagnosis in the current study. Table S2. Anatomical Therapeutic Chemical (ATC) codes used for drugs in the current study. Table S3. Characteristics of the study patients with and without use of pioglitazone before propensity score matching.